| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 1.97e-03 | 294 | 5 | 2 | GO:0002221 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 2.21e-03 | 312 | 5 | 2 | GO:0002758 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 2.52e-03 | 333 | 5 | 2 | GO:0002218 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | 3.97e-03 | 420 | 5 | 2 | GO:0045089 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | 4.57e-03 | 451 | 5 | 2 | GO:0002833 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | 6.01e-03 | 519 | 5 | 2 | GO:0045088 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 6.80e-03 | 553 | 5 | 2 | GO:0002757 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | 7.69e-03 | 589 | 5 | 2 | GO:0031349 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 8.36e-03 | 615 | 5 | 2 | GO:0002764 | |
| GeneOntologyBiologicalProcess | activation of immune response | 8.57e-03 | 623 | 5 | 2 | GO:0002253 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | 9.11e-03 | 643 | 5 | 2 | GO:0002831 | |
| Domain | Znf_C2H2-like | 1.66e-02 | 796 | 5 | 2 | IPR015880 | |
| Domain | Znf_C2H2 | 1.70e-02 | 805 | 5 | 2 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.71e-02 | 808 | 5 | 2 | SM00355 | |
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 11389905 | ||
| Pubmed | ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. | 2.48e-07 | 6 | 5 | 2 | 21885437 | |
| Pubmed | 3.47e-07 | 7 | 5 | 2 | 15474016 | ||
| Pubmed | 8.19e-06 | 32 | 5 | 2 | 19285159 | ||
| Pubmed | ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB. | 1.56e-05 | 44 | 5 | 2 | 34839354 | |
| Pubmed | 1.57e-05 | 1477 | 5 | 4 | 31515488 | ||
| Pubmed | TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | 1.11e-04 | 117 | 5 | 2 | 36898370 | |
| Interaction | KATNAL2 interactions | 1.86e-05 | 28 | 5 | 2 | int:KATNAL2 | |
| Interaction | TNIP3 interactions | 2.75e-05 | 34 | 5 | 2 | int:TNIP3 | |
| Interaction | AZI2 interactions | 3.83e-05 | 40 | 5 | 2 | int:AZI2 | |
| Interaction | C11orf98 interactions | 4.64e-05 | 44 | 5 | 2 | int:C11orf98 | |
| Interaction | PCLAF interactions | 6.75e-05 | 53 | 5 | 2 | int:PCLAF | |
| Interaction | TBK1 interactions | 7.65e-05 | 402 | 5 | 3 | int:TBK1 | |
| Interaction | NOTCH2 interactions | 8.90e-05 | 423 | 5 | 3 | int:NOTCH2 | |
| Interaction | NSUN5 interactions | 8.96e-05 | 61 | 5 | 2 | int:NSUN5 | |
| Interaction | PPP1R12B interactions | 1.11e-04 | 68 | 5 | 2 | int:PPP1R12B | |
| Interaction | OTUD7B interactions | 1.25e-04 | 72 | 5 | 2 | int:OTUD7B | |
| Interaction | PLEKHB2 interactions | 1.25e-04 | 72 | 5 | 2 | int:PLEKHB2 | |
| Interaction | MAP1LC3C interactions | 1.25e-04 | 72 | 5 | 2 | int:MAP1LC3C | |
| Interaction | LITAF interactions | 1.43e-04 | 77 | 5 | 2 | int:LITAF | |
| Interaction | CNN2 interactions | 1.54e-04 | 80 | 5 | 2 | int:CNN2 | |
| Interaction | MAZ interactions | 1.78e-04 | 86 | 5 | 2 | int:MAZ | |
| Interaction | APEH interactions | 1.83e-04 | 87 | 5 | 2 | int:APEH | |
| Interaction | PPIL2 interactions | 1.83e-04 | 87 | 5 | 2 | int:PPIL2 | |
| Interaction | CCT8 interactions | 1.94e-04 | 550 | 5 | 3 | int:CCT8 | |
| Interaction | RP9 interactions | 2.37e-04 | 99 | 5 | 2 | int:RP9 | |
| Interaction | TRAF2 interactions | 2.55e-04 | 603 | 5 | 3 | int:TRAF2 | |
| Interaction | IKBKE interactions | 2.71e-04 | 106 | 5 | 2 | int:IKBKE | |
| Interaction | OSBPL3 interactions | 2.92e-04 | 110 | 5 | 2 | int:OSBPL3 | |
| Interaction | SLC25A22 interactions | 3.59e-04 | 122 | 5 | 2 | int:SLC25A22 | |
| Interaction | EFEMP1 interactions | 3.65e-04 | 123 | 5 | 2 | int:EFEMP1 | |
| Interaction | CMSS1 interactions | 3.71e-04 | 124 | 5 | 2 | int:CMSS1 | |
| Interaction | RIOK2 interactions | 3.83e-04 | 126 | 5 | 2 | int:RIOK2 | |
| Interaction | EEF1E1 interactions | 4.01e-04 | 129 | 5 | 2 | int:EEF1E1 | |
| Interaction | GLG1 interactions | 4.20e-04 | 132 | 5 | 2 | int:GLG1 | |
| Interaction | RNF115 interactions | 4.33e-04 | 134 | 5 | 2 | int:RNF115 | |
| Interaction | AGK interactions | 4.33e-04 | 134 | 5 | 2 | int:AGK | |
| Interaction | UACA interactions | 4.46e-04 | 136 | 5 | 2 | int:UACA | |
| Interaction | GTF2B interactions | 4.79e-04 | 141 | 5 | 2 | int:GTF2B | |
| Interaction | FAM168A interactions | 4.86e-04 | 142 | 5 | 2 | int:FAM168A | |
| Interaction | SDC2 interactions | 4.93e-04 | 143 | 5 | 2 | int:SDC2 | |
| Interaction | GABARAP interactions | 5.07e-04 | 145 | 5 | 2 | int:GABARAP | |
| Interaction | CPSF3 interactions | 5.14e-04 | 146 | 5 | 2 | int:CPSF3 | |
| Interaction | RAB18 interactions | 5.21e-04 | 147 | 5 | 2 | int:RAB18 | |
| Interaction | CCDC86 interactions | 5.50e-04 | 151 | 5 | 2 | int:CCDC86 | |
| Interaction | BTF3 interactions | 5.85e-04 | 799 | 5 | 3 | int:BTF3 | |
| Interaction | SLTM interactions | 5.86e-04 | 156 | 5 | 2 | int:SLTM | |
| Interaction | TAF4 interactions | 5.86e-04 | 156 | 5 | 2 | int:TAF4 | |
| Interaction | FAM161A interactions | 5.86e-04 | 156 | 5 | 2 | int:FAM161A | |
| Interaction | GABARAPL1 interactions | 5.94e-04 | 157 | 5 | 2 | int:GABARAPL1 | |
| Interaction | TCEA2 interactions | 6.09e-04 | 159 | 5 | 2 | int:TCEA2 | |
| Interaction | PIP4K2C interactions | 6.09e-04 | 159 | 5 | 2 | int:PIP4K2C | |
| Interaction | RNF11 interactions | 6.88e-04 | 169 | 5 | 2 | int:RNF11 | |
| Interaction | IGHG1 interactions | 6.88e-04 | 169 | 5 | 2 | int:IGHG1 | |
| Interaction | FBF1 interactions | 7.04e-04 | 171 | 5 | 2 | int:FBF1 | |
| Interaction | DPM1 interactions | 7.20e-04 | 173 | 5 | 2 | int:DPM1 | |
| Interaction | GLMN interactions | 7.20e-04 | 173 | 5 | 2 | int:GLMN | |
| Interaction | GPC1 interactions | 7.71e-04 | 179 | 5 | 2 | int:GPC1 | |
| Interaction | NRSN1 interactions | 7.71e-04 | 179 | 5 | 2 | int:NRSN1 | |
| Interaction | GABARAPL2 interactions | 7.97e-04 | 182 | 5 | 2 | int:GABARAPL2 | |
| Interaction | AIP interactions | 7.97e-04 | 182 | 5 | 2 | int:AIP | |
| Interaction | DAZAP2 interactions | 8.32e-04 | 186 | 5 | 2 | int:DAZAP2 | |
| Interaction | KIDINS220 interactions | 8.41e-04 | 187 | 5 | 2 | int:KIDINS220 | |
| Interaction | TNFAIP3 interactions | 8.77e-04 | 191 | 5 | 2 | int:TNFAIP3 | |
| Interaction | PIBF1 interactions | 9.61e-04 | 200 | 5 | 2 | int:PIBF1 | |
| Interaction | PIGT interactions | 9.70e-04 | 201 | 5 | 2 | int:PIGT | |
| Interaction | RPS27L interactions | 1.02e-03 | 206 | 5 | 2 | int:RPS27L | |
| Interaction | DEK interactions | 1.05e-03 | 209 | 5 | 2 | int:DEK | |
| Interaction | PTDSS1 interactions | 1.08e-03 | 212 | 5 | 2 | int:PTDSS1 | |
| Interaction | ATAD3B interactions | 1.09e-03 | 213 | 5 | 2 | int:ATAD3B | |
| Interaction | TANK interactions | 1.12e-03 | 216 | 5 | 2 | int:TANK | |
| Interaction | HEATR1 interactions | 1.18e-03 | 222 | 5 | 2 | int:HEATR1 | |
| Interaction | NCOA3 interactions | 1.20e-03 | 224 | 5 | 2 | int:NCOA3 | |
| Interaction | DNAJC11 interactions | 1.20e-03 | 224 | 5 | 2 | int:DNAJC11 | |
| Interaction | NSA2 interactions | 1.21e-03 | 225 | 5 | 2 | int:NSA2 | |
| Interaction | TGM1 interactions | 1.25e-03 | 228 | 5 | 2 | int:TGM1 | |
| Interaction | NFKBIA interactions | 1.25e-03 | 228 | 5 | 2 | int:NFKBIA | |
| Interaction | COPG1 interactions | 1.26e-03 | 229 | 5 | 2 | int:COPG1 | |
| Interaction | GPATCH4 interactions | 1.29e-03 | 232 | 5 | 2 | int:GPATCH4 | |
| Interaction | IKBKB interactions | 1.30e-03 | 233 | 5 | 2 | int:IKBKB | |
| Interaction | NACA interactions | 1.31e-03 | 234 | 5 | 2 | int:NACA | |
| Interaction | CDC20 interactions | 1.31e-03 | 234 | 5 | 2 | int:CDC20 | |
| Interaction | BIRC2 interactions | 1.33e-03 | 236 | 5 | 2 | int:BIRC2 | |
| Interaction | TXLNA interactions | 1.33e-03 | 236 | 5 | 2 | int:TXLNA | |
| Interaction | MAP7 interactions | 1.37e-03 | 239 | 5 | 2 | int:MAP7 | |
| Interaction | TUBB4A interactions | 1.43e-03 | 244 | 5 | 2 | int:TUBB4A | |
| Interaction | TAF6 interactions | 1.44e-03 | 245 | 5 | 2 | int:TAF6 | |
| Interaction | SLC25A12 interactions | 1.50e-03 | 250 | 5 | 2 | int:SLC25A12 | |
| Interaction | HDAC1 interactions | 1.52e-03 | 1108 | 5 | 3 | int:HDAC1 | |
| Interaction | DOCK7 interactions | 1.54e-03 | 254 | 5 | 2 | int:DOCK7 | |
| Interaction | SLC25A11 interactions | 1.56e-03 | 255 | 5 | 2 | int:SLC25A11 | |
| Interaction | ABCD3 interactions | 1.60e-03 | 259 | 5 | 2 | int:ABCD3 | |
| Interaction | CHERP interactions | 1.64e-03 | 262 | 5 | 2 | int:CHERP | |
| Interaction | SLC25A13 interactions | 1.65e-03 | 263 | 5 | 2 | int:SLC25A13 | |
| Interaction | GNAS interactions | 1.67e-03 | 264 | 5 | 2 | int:GNAS | |
| Interaction | SLC25A1 interactions | 1.74e-03 | 270 | 5 | 2 | int:SLC25A1 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 4.33e-06 | 200 | 5 | 3 | M7781 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 5.48e-04 | 196 | 5 | 2 | M8970 | |
| Coexpression | GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP | 5.54e-04 | 197 | 5 | 2 | M8586 | |
| Coexpression | GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 5.65e-04 | 199 | 5 | 2 | M8551 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 5.65e-04 | 199 | 5 | 2 | M4142 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | 5.71e-04 | 200 | 5 | 2 | M5812 | |
| Coexpression | GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 5.71e-04 | 200 | 5 | 2 | M9768 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP | 5.71e-04 | 200 | 5 | 2 | M9633 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP | 5.71e-04 | 200 | 5 | 2 | M9658 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP | 5.71e-04 | 200 | 5 | 2 | M7233 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 5.71e-04 | 200 | 5 | 2 | M7529 | |
| Coexpression | GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP | 5.71e-04 | 200 | 5 | 2 | M7783 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN | 5.71e-04 | 200 | 5 | 2 | M5232 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 5.71e-04 | 200 | 5 | 2 | M9628 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 2.63e-03 | 433 | 5 | 2 | M2240 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP | 2.76e-03 | 443 | 5 | 2 | M40870 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 2.77e-03 | 444 | 5 | 2 | M41713 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | 4.18e-03 | 548 | 5 | 2 | M16859 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 5.19e-03 | 612 | 5 | 2 | MM3804 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 7.40e-03 | 734 | 5 | 2 | M3835 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | 9.71e-03 | 844 | 5 | 2 | M41129 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 2.04e-02 | 1242 | 5 | 2 | M1920 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 2.28e-02 | 1316 | 5 | 2 | MM1052 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 2.56e-02 | 1399 | 5 | 2 | M535 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.66e-03 | 469 | 5 | 2 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.68e-03 | 564 | 5 | 2 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.46e-03 | 597 | 5 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.26e-03 | 629 | 5 | 2 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| Drug | 2brn | 1.82e-04 | 98 | 5 | 2 | CID004369434 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.19e-04 | 181 | 5 | 2 | 1077_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 7.10e-04 | 194 | 5 | 2 | 3454_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 7.18e-04 | 195 | 5 | 2 | 7444_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 7.18e-04 | 195 | 5 | 2 | 7509_DN | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | 7.25e-04 | 196 | 5 | 2 | 592_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.25e-04 | 196 | 5 | 2 | 6273_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 3335_DN | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A | 7.40e-04 | 198 | 5 | 2 | 1411_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 7.40e-04 | 198 | 5 | 2 | 6001_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 7.40e-04 | 198 | 5 | 2 | 6262_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | 7.40e-04 | 198 | 5 | 2 | 1553_UP | |
| Drug | STOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A | 7.47e-04 | 199 | 5 | 2 | 6906_UP | |
| Drug | nickel chloride | 1.28e-03 | 1178 | 5 | 3 | ctd:C022838 | |
| Disease | Malignant neoplasm of breast | 4.55e-04 | 1074 | 5 | 3 | C0006142 | |
| Disease | alkaline phosphatase measurement | 1.10e-02 | 1015 | 5 | 2 | EFO_0004533 | |
| Disease | C-reactive protein measurement | 1.54e-02 | 1206 | 5 | 2 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLCHPLPLPSYLHHT | 31 | Q9N2K0 | |
| CLPYPIEHPYHTHIC | 141 | Q8N865 | |
| CLYPYPVHHPCDRQS | 226 | Q9NWT6 | |
| HLECHYTLTPYIHPH | 31 | Q86VP1 | |
| HVEPHPEHLCGAYPY | 536 | Q15025 | |
| PHASYEPELHPAVCY | 126 | P62380 | |
| RLHAQYRPYHCPHCP | 286 | O15015 |